Opportunities
Active Solicitations
Closed Solicitations
| RPP Identifier | Date Released | Requirement Topic | Description | Requiring Office | Submission Due Date |
|---|
| Type | Release Date | Requirement Topic | Closed Date |
|---|---|---|---|
| RPP-26-02-AM-LVP | 2/6/2026 | 3/16/2026 | |
| Market Research | 1/26/2026 | Market Research: Stabilization Technologies for CBRN Medical Countermeasures | 2/19/2026 |
| RPP-26-10-VHF | 10/15/2025 | Domestic Capability Building Activity – Onshoring the Manufacturing of Viral Hemorrhagic Fever Vaccine Candidates | 12/11/2025 |
| RPP-25-11-Smart Ab | 9/10/2025 | Antibody (Ab) Advanced Manufacturing Capability Improvement: Smart Technologies | 10/22/2025 |
| Market Research | 8/6/2025 | Market Research Survey: Personal Protective Equipment Manufacturing | 8/26/2025 |
| Market Research | 3/26/2025 | Market Research Survey for Adherent Cell Culture Manufacturing | 4/9/2025 |
| Market Research | 11/07/2024 | Market Research Survey for Pichia Expression System Capabilities | 11/21/2024 |
| RPP-24-05-N95 | 8/2/2024 | Sustainment of N95 Respirator Manufacturing Capacity | 8/22/2024 |
| RPP-24-06-Pipette | 6/27/2024 | Industrial Base Expansion of injection molded pipette tips and centrifuge tubes for use in the vaccine manufacturing and pandemic response supply chain | 7/25/2024 |
| RPP-24-07-mAbs | 6/24/2024 | Manufacturing Optimization for Filovirus Monoclonal Antibodies | 8/05/2024 |
| Request for Information | 3/20/2024 | Request for Information regarding Manufacturing Optimization for Filovirus Human Monoclonal Antibodies | 4/20/2024 |
| RPP-24-03-Sterilization | 3/01/2024 | Sterilization Capacity for Vaccines and Therapeutics | 3/28/2024 |
| RPP-24-02-KSM-API | 2/21/2024 | Production of Drug Substances and Drug Products at Commercial Scale | 3/20/2024 |
| RPP-24-01-SmallMol | 1/11/2024 | Production of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale | 2/01/2024 |